BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29517696)

  • 1. Role of IL-28B genetic variants in HCV-related liver disease severity in patients with different viral genotypes.
    Huang CI; Huang CF; Yeh ML; Lin YH; Liang PC; Liu SV; Hsieh MH; Lin ZY; Chen SC; Huang JF; Chuang WL; Dai CY; Yu ML
    Medicine (Baltimore); 2018 Mar; 97(10):e9782. PubMed ID: 29517696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of serum level and genetic variation of IL-28B in interferon responsiveness and advanced liver disease in chronic hepatitis C patients.
    Alborzi A; Hashempour T; Moayedi J; Musavi Z; Pouladfar G; Merat S
    Med Microbiol Immunol; 2017 Apr; 206(2):165-174. PubMed ID: 28214926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infection.
    Kitson MT; George J; Dore GJ; Leung R; Button P; McCaughan GW; Grawford DH; Siebert W; Weltman MD; Cheng WS; Roberts SK
    J Gastroenterol Hepatol; 2014; 29(7):1458-62. PubMed ID: 25587616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-28B gene non-TT allele strongly predicts treatment failure for genotype 1 infected chronic hepatitis C patients with advanced fibrosis: a case control study.
    Hu CC; Lin CL; Chang LC; Chien CH; Chen LW; Liu CJ; Chien RN
    BMC Infect Dis; 2015 Mar; 15():156. PubMed ID: 25888020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of host genetic IL-28B variants in hepatitis C virus genotype 1 Asian patients retreated with pegylated interferon plus ribavirin.
    Huang CF; Yeh ML; Hsieh MH; Hsieh MY; Lin ZY; Chen SC; Wang LY; Huang JF; Juo SH; Lin YC; Dai CY; Chuang WL; Yu ML
    J Gastroenterol Hepatol; 2013 Sep; 28(9):1515-20. PubMed ID: 23560893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients.
    Yu ML; Huang CF; Huang JF; Chang NC; Yang JF; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Li YN; Wu MS; Dai CY; Juo SH; Chuang WL
    Hepatology; 2011 Jan; 53(1):7-13. PubMed ID: 21254157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis C.
    Mah YH; Liu CH; Chen CL; Tseng TC; Liu CJ; Chen PJ; Chen DS; Kao JH
    J Formos Med Assoc; 2016 Nov; 115(11):953-960. PubMed ID: 27751759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin.
    Huang CF; Huang JF; Yang JF; Hsieh MY; Lin ZY; Chen SC; Wang LY; Juo SH; Chen KC; Chuang WL; Kuo HT; Dai CY; Yu ML
    J Hepatol; 2012 Jan; 56(1):34-40. PubMed ID: 21703176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between the genetic variations in interleukin 28B and chronic hepatitis C virus genotypes in the Chinese population.
    Mao XR; Zhang LT; Chen H; Xiao P; Zhang YC
    Mol Med Rep; 2014 Aug; 10(2):1037-45. PubMed ID: 24840747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infection.
    Huang CF; Dai CY; Yeh ML; Huang CI; Tai CM; Hsieh MH; Liang PC; Lin YH; Hsieh MY; Yang HL; Huang JF; Lin ZY; Chen SC; Yu ML; Chuang WL
    J Hepatol; 2015 Mar; 62(3):512-8. PubMed ID: 25457210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4.
    Attallah AM; Omran D; Marie MS; Abdelrazek M; Salama A; El Essawey R; Mobarak L; Maklad S; Omar A
    Br J Biomed Sci; 2018 Oct; 75(4):157-162. PubMed ID: 29914308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of host IL28B rs12979860, rs8099917 in interferon responsiveness and advanced liver disease in chronic genotype 3 hepatitis C patients.
    Firdaus R; Biswas A; Saha K; Mukherjee A; Chaudhuri S; Chandra A; Konar A; Sadhukhan PC
    PLoS One; 2014; 9(6):e99126. PubMed ID: 24914551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection.
    Marabita F; Aghemo A; De Nicola S; Rumi MG; Cheroni C; Scavelli R; Crimi M; Soffredini R; Abrignani S; De Francesco R; Colombo M
    Hepatology; 2011 Oct; 54(4):1127-34. PubMed ID: 21721028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of IL-28B and ITPA genotypes in Chinese Han population infected persistently with hepatitis C virus genotype 6 or HCV-1.
    Zhang XH; Cai QX; Hong CX; Lin CS; Zhao ZX
    J Med Virol; 2013 Jul; 85(7):1163-9. PubMed ID: 23918534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependent.
    D'Ambrosio R; Aghemo A; De Francesco R; Rumi MG; Galmozzi E; De Nicola S; Cheroni C; Clark PJ; Ronchi G; Lampertico P; Colombo M
    Int J Mol Sci; 2014 Apr; 15(5):7213-24. PubMed ID: 24776764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-28B polymorphisms on the SVR in the treatment of naïve chronic hepatitis C with pegylated interferon-α plus ribavirin: a meta-analysis.
    Shi KQ; Liu WY; Lin XF; Fan YC; Chen YP; Zheng MH
    Gene; 2012 Oct; 507(1):27-35. PubMed ID: 22842190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of hepatitis C virus and IL28B genotypes on liver stiffness.
    Lundbo LF; Clausen LN; Weis N; Schønning K; Rosenørn L; Benfield T; Christensen PB
    PLoS One; 2014; 9(12):e115882. PubMed ID: 25545640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of IL-28B polymorphisms on pegylated interferon plus ribavirin treatment response in children and adolescents infected with HCV genotypes 1 and 4.
    Domagalski K; Pawłowska M; Tretyn A; Halota W; Pilarczyk M; Smukalska E; Linkowska K; Grzybowski T
    Eur J Clin Microbiol Infect Dis; 2013 Jun; 32(6):745-54. PubMed ID: 23314745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of response to pegylated-interferon-α and ribavirin therapy in Chinese patients infected with different hepatitis C virus genotype.
    Guo X; Zhao Z; Xie J; Cai Q; Zhang X; Peng L; Gao Z
    Virol J; 2012 Jun; 9():123. PubMed ID: 22713131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL28B polymorphism as a predictor of antiviral response in chronic hepatitis C.
    Cieśla A; Bociąga-Jasik M; Sobczyk-Krupiarz I; Głowacki MK; Owczarek D; Cibor D; Sanak M; Mach T
    World J Gastroenterol; 2012 Sep; 18(35):4892-7. PubMed ID: 23002361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.